BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11236211)

  • 1. The development of antibiotic resistance in Propionibacterium acnes.
    Leyden J; Levy S
    Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ
    Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
    Gans EH; Kligman AM
    J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
    Leyden J; Kaidbey K; Levy SF
    Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
    Leyden JJ; Wortzman M; Baldwin EK
    Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
    Kircik L
    Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
    Leyden JJ
    J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH; Kim IH; Seo JJ
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact and importance of resistance.
    Tanghetti E
    Cutis; 2007 Jul; 80(1 Suppl):5-9. PubMed ID: 17824580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 15. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.
    Leyden JJ; Preston N; Osborn C; Gottschalk RW
    J Clin Aesthet Dermatol; 2011 May; 4(5):22-6. PubMed ID: 21607190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
    Tschen E; Jones T
    J Drugs Dermatol; 2002 Sep; 1(2):153-7. PubMed ID: 12847739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients.
    Eady EA; Farmery MR; Ross JI; Cove JH; Cunliffe WJ
    Br J Dermatol; 1994 Sep; 131(3):331-6. PubMed ID: 7918006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach.
    Leyden JJ; Del Rosso JQ
    J Drugs Dermatol; 2012 Jul; 11(7):830-3. PubMed ID: 22777224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.